You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 298 No. 16, October 24/31, 2007 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Extract
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related letter
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Hypertension
 •Alert me on articles by topic

Cocoa Intake and Blood Pressure

To the Editor: In their study of cocoa intake and blood pressure, Dr Taubert and colleagues1 concluded that the reduction of diastolic and systolic blood pressure caused by dark chocolate intake was due to increased formation of S-nitrosoglutathione. Many biochemical markers were measured in the study using commercially available assays or reported methods. However, we are not aware of reports of the analytical performance of the liquid chromatography tandem mass spectrometry method used for the measurement of plasma S-nitrosoglutathione. This is potentially an important problem for research involving S-nitrosothiols, for which the reported concentrations in biological fluids has a 3–order magnitude range.2

We are also unaware of previous reports of achieving measurement (with a lower limit of detection of 0.1 nmol/L) of such low plasma baseline levels of S-nitrosoglutathione (0.33 nmol/L) by liquid chromatography tandem mass spectrometry.2-3 Such methods require full validation to avoid analytical errors; this is particularly true regarding research on the physiological roles of S-nitrosothiols, as well as the relative importance of individual S-nitrosothiols such as S-nitrosoglutathione.

We believe that accurate liquid chromatography tandem mass spectrometry analysis of S-nitrosothiols is best performed by use of stable-isotope labeled analogues as internal standards. Use at high molar excess of a chemically unrelated compound like thiamazole (which carries a sulfhydryl group) as in the study by Taubert et al would be expected to lead to a reaction with S-nitrosoglutathione, thus diminishing its concentration.

Finally, S-nitrosoglutathione in humans is a selective inhibitor of platelet aggregation.4 Clinical studies involving S-nitrosoglutathione preferably include measurement of platelet aggregation. Since S-nitrosoglutathione infusion in humans has not resulted in reduction of blood pressure,4-5 it is unlikely that the blood pressure decrease observed in the study by Taubert et al is attributable to S-nitrosoglutathione, at least at the measured S-nitrosoglutathione concentrations.

Financial Disclosures: None reported.

Dimitrios Tsikas, PhD
tsikas.dimitros{at}mh-hannover.de
Institute of Clinical Pharmacology
Hannover Medical School
Hannover, Germany

Ranieri Rossi, PhD
Department of Evolutionary Biology
Laboratory of Pharmacology and Toxicology
University of Siena
Siena, Italy

1. Taubert D, Roesen R, Lehmann C, Jung N, Schömig E. Effects of low habitual cocoa intake on blood pressure and bioactive nitric oxide. JAMA. 2007;298(1):49-60. FREE FULL TEXT
2. Giustarini D, Milzani A, Dalle-Donne I, Rossi R. Detection of S-nitrosothiols in biological fluids: a comparison among the most widely applied methodologies. J Chromatogr B Analyt Technol Biomed Life Sci. 2007;851(1-2):124-139. FULL TEXT | ISI | PUBMED
3. Rellán-Álvarez R, Hernández LE, Abadía J, Álvarez-Fernández A. Direct and simultaneous determination of reduced and oxidized glutathione and homoglutathione by liquid chromatography-electrospray/mass spectrometry in plant tissue extracts. Anal Biochem. 2006;356(2):254-264. FULL TEXT | ISI | PUBMED
4. de Belder AJ, MacAllister R, Radomski MW, Moncada S, Vallance PJ. Effects of S-nitroso-glutathione in the human forearm circulation: evidence for selective inhibition of platelet activation. Cardiovasc Res. 1994;28(5):691-694. ISI | PUBMED
5. Ramsay B, Radomski M, de Belder A, Martin JF, Lopez-Jaramillo P. Systemic effects of S-nitroso-glutathione in the human following intravenous infusion. Br J Clin Pharmacol. 1995;40(1):101-102. ISI | PUBMED

Letters Section Editor: Robert M. Golub, MD, Senior Editor.

JAMA. 2007;298:1862-1863.


RELATED LETTER

Cocoa Intake and Blood Pressure—Reply
Dirk Taubert, Norma Jung, and Renate Roesen
JAMA. 2007;298(16):1863-1864.
EXTRACT | FULL TEXT  

RELATED ARTICLE

Effects of Low Habitual Cocoa Intake on Blood Pressure and Bioactive Nitric Oxide: A Randomized Controlled Trial
Dirk Taubert, Renate Roesen, Clara Lehmann, Norma Jung, and Edgar Schömig
JAMA. 2007;298(1):49-60.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.